Radiation for Breast Cancer: 603 Real Stories

603 stories match breast cancer and radiation. 562 of them mention surgery.

Sarah, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Sarah's Patient Story

Patient Info: Sarah, Female, 40s | Stage III

Biomarkers: Estrogen/progesterone-sensitive breast cancer mentioned; exact receptor labels not reported

As of June 2023, Sarah had lived through incurable salivary gland cancer and Stage III breast cancer, completed major breast cancer treatment, paused hormone therapy to pursue IVF under medical guidance, delivered her daughter at 48, and was advocating for people with cancer; no cancer-free or NED status was stated.

The Patient Story
OutcomeCare Ongoing
Sarah, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III HR-Positive Breast Cancer: Sarah's Survivor Story

Patient Info: Sarah McDonald, Female, 40s | Stage III

Biomarkers: ER-positive; PR-positive; HER2-negative

Sarah was 10 years from diagnosis without a recurrence and described the breast cancer as successfully treated. She later paused hormone therapy, completed IVF and gave birth at age 48.

The Patient Story
OutcomeCancer-Free / Long-Term Survivor
Christine, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III HER2-Positive Breast Cancer: Christine's Survivor Story

Patient Info: Christine Elliott, Female, Under 40 | Stage III

Biomarkers: Estrogen receptor-positive; HER2 and progesterone receptor status not reported

As of May 2023, Christine was about 3 years from diagnosis and in survivorship after chemotherapy, lumpectomy, and radiation. She reported lasting physical and emotional effects but did not state a formal NED status.

YouTube — The Patient Story
OutcomeSurvivorship / Completed Treatment
Valerie, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Valerie's Patient Story

Patient Info: Valerie Frank, Female, 40s | Stage IV

Metastatic Site: bone, lung, liver

Living with Stage IV breast cancer after recurrence in the bones, lungs and liver in January 2022, with oncology and palliative care support.

Dana-Farber
OutcomeLiving With Cancer
Abigail, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HR-Positive Breast Cancer: Abigail's Patient Story

Patient Info: Abigail Myers, female, Under 40 | Stage IV

Biomarkers: ER-positive, PR-positive, HER2-positive

Metastatic Site: bones, brain

Abigail continued living with Stage IV metastatic breast cancer after about 8 years of multiple treatment lines, including therapy for bone and brain metastases.

Dana-Farber
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Chemotherapy complication: methotrexate absorbed into the bloodstream after spinal injection

Patient Info: Anonymized, Female | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative; Oncotype DX Recurrence Score 20

Metastatic Site: leptomeninges / central nervous system; brain

Five months after leptomeningeal carcinomatosis was recognised, she developed a new 2 cm brain lesion and neurological decline. Her family chose supportive care, and she died 10 days after transfer to inpatient hospice.

PubMed Central
OutcomeIn Memory
Renée, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Renée's Patient Story

Patient Info: Renée, Female, Under 40 | Stage II

Biomarkers: Not genetically inherited; breast cancer linked by her team to prior doxorubicin exposure and total-body radiation

As of February 2023, Renée described stable health, working treatments, good bloodwork, and ongoing long-term hormone/anti-cancer therapy; she did not consider herself cancer-free and preferred survivor/thriver language.

The Patient Story
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Rare breast cancer subtype that recurred years later in a more aggressive form

Patient Info: Anonymized, Female | Stage IV

Biomarkers: CD117 focally positive in the transformed component; high Ki-67; hormone-receptor status was unknown at the original diagnosis

Metastatic Site: lungs

One year after treatment for the late chest-wall recurrence, CT showed another local recurrence and metastatic nodules in both lungs. She chose to continue treatment elsewhere.

PubMed Central
OutcomeSetback / Progression
Lucy, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Lucy's Survivor Story

Patient Info: Lucy E., Female, Under 40

Biomarkers: BRCA1 mutation; triple-negative breast cancer

As of January 2023, Lucy had been told she was all-clear/cancer-free after chemotherapy, had undergone double mastectomy with staged reconstruction planning, and was continuing close oncology reviews every 3-4 months.

The Patient Story
OutcomeCancer-Free / NED
Anne, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Anne's Patient Story

Patient Info: Anne, Female, 50s | Stage II

As of 2023, Anne was receiving/continuing care for Stage II breast cancer after lumpectomy, paclitaxel chemotherapy, radiation therapy, and a targeted-therapy plan reduced to 9 rounds by insurance coverage.

Our Cancer Stories
OutcomeCare Ongoing
Gayna, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Gayna's Survivor Story

Patient Info: Gayna, Female, 50s | Stage I

Gayna completed treatment for Stage I breast cancer and described optimism, thankfulness, permanent diet/exercise changes, and plans to stay well and enjoy life.

Our Cancer Stories
OutcomeSurvivorship / Completed Treatment
Maiv, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Maiv's Patient Story

Patient Info: Maiv | Stage II

Maiv had completed active treatment and remained on hormone therapy at the time of her story.

Our Cancer Stories
OutcomeCare Ongoing
Annie, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Annie's Patient Story

Patient Info: Annie, Female, 40s | Stage II

As of 2023, Annie was still receiving care for Stage II breast cancer after completing chemotherapy and hormonal therapy, with lumpectomy, lymphadenectomy, radiation therapy, and immunotherapy still ahead in her plan.

Our Cancer Stories
OutcomeCare Ongoing
Grace, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Grace's Patient Story

Patient Info: Grace, Female, 60s | Stage II

Grace was still in treatment for Stage II breast cancer, including lumpectomy-based care, chemotherapy, radiation therapy, and immunotherapy, and reported that treatment was working despite difficult side effects and job loss.

Our Cancer Stories
OutcomeResponding Well
Margaret, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Margaret's Patient Story

Patient Info: Margaret | Stage III

Margaret remained hopeful while managing severe treatment effects, sepsis, financial pressure, and reduced time with her children.

Our Cancer Stories
OutcomeNot reported
Hu, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Hu's Patient Story

Patient Info: Hu Jia, Female | Stage I

As of 2023, Hu Jia was in treatment for Stage I breast cancer after choosing a modified plan that excluded lymphadenectomy, while anticipating future medication costs and focusing on diet, art, reflection, and emotional resilience.

Our Cancer Stories
OutcomeCare Ongoing
Lan, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Lan's Patient Story

Patient Info: Lan | Stage II

Lan had completed surgery, chemotherapy, and radiation and remained on hormone therapy, with ongoing concern about treatment effects but growing optimism.

Our Cancer Stories
OutcomeCare Ongoing
Rose, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Rose's Patient Story

Patient Info: Rose | Stage II

Rose remains on radiotherapy, hormone therapy and targeted therapy while continuing to live with concerns about recurrence and metastasis.

Our Cancer Stories
OutcomeCare Ongoing